text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 475207-59-1 | Product Number: N1229

Sorafenib Tosylate


Purity: >98.0%(T)(HPLC)
Synonyms:
  • 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-N-methylpicolinamide 4-Methylbenzenesulfonate
  • 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamamido]phenoxy]-N-methyl-2-pyridinecarboxamide 4-Methylbenzenesulfonate
Product Documents:
1G
€76.00
5   37  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number N1229
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__2__1H__1__6ClF__3N__4O__3.C__7H__8O__3S = 637.03 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive,Heat Sensitive
CAS RN 475207-59-1
Reaxys Registry Number 11116227
MDL Number

MFCD08235032

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Neutralization titration) min. 98.0 %
Melting point 222.0 to 226.0 °C
NMR confirm to structure
Properties (reference)
Melting Point 224 °C
GHS
Pictogram Pictogram
Signal Word Danger
Hazard Statements H360 : May damage fertility or the unborn child.
H362 : May cause harm to breast-fed children.
Precautionary Statements P263 : Avoid contact during pregnancy and while nursing.
P260 : Do not breathe dust.
P202 : Do not handle until all safety precautions have been read and understood.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
Related Laws:
RTECS# US4588880
Transport Information:
HS Number 2933399990
Application
Sorafenib Tosylate: An Orally Active Multikinase Inhibitor

Sorafenib tosylate (BAY 43-9006) is an orally active multikinase inhibitor that decrease tumor cell proliferation. There are reports that sorafenib is shown to inhibits cell surface tyrosine kinase receptors (KIT, FLT- 3, RET, RET/PTC, VEGFR-1, VEGFR- 2, VEGFR- 3, and PDGFR-ß: platelet-derived growth factor receptor-β) and downstream intracellular serine/threonine kinases (c-CRAF, BRAF and mutant BRAF) in vitro.1-3) Several of these kinases are thought to be involved in tumor cell signaling, angiogenesis and apoptosis.4,5) In clinical, sorafenib tosylate is used for the treatment of renal cell carcinoma and hepatocellular carcinoma. (The product is for research purpose only.)

References


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Life Science
Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.